LA JOLLA, Calif., Feb. 23 /PRNewswire/ -- I3 Corporation announced today that the Company will be presenting on its lead product, the Q-FLO(TM) closed system, as a superior alternative to conventional closed systems for medication transport and delivery, at the In3 West Conference on March 4-5, 2010, at the Venetian Resort in Las Vegas, NV.
"The Q-FLO(TM) represents a significant advance in the state of the art of closed system devices, offering improved safety and convenience for healthcare workers administering cytotoxic drugs to patients around the world," stated Babak Nemati, Ph.D., President & CEO of I3. "We are proud of the accomplishments of our design and development team, and we look forward to the commercial launch of this important product line with our distribution partners later this year."
About I3 Corporation (www.infusioninnovations.net)
I3 is a La Jolla, California, based emerging medical device company focused on the design and development of innovative products for improved safety of the hospital environment. Founded in 2006, I3 has a strong proprietary portfolio of products ranging from needle-less injection site connectors, to safety syringes, and bio-diagnostic sampling devices. The fundamental driving philosophy behind our products is bringing key engineering innovation to improve safety, ease of use, and functionality of established hospital based products.